Next, CR-1 expression was assessed immunohistochemically in pathological specimens consisting of 239 benign prostatic hyperplasia (BPH), and 211 PCa cases that were treated by surgical intervention. The gene discussed is CR1; the disease is posterior cortical atrophy.